Literature DB >> 15128050

Promoter polymorphisms in glutathione-S-transferase genes affect transcription.

Carol A Guy1, Bastiaan Hoogendoorn, S Kaye Smith, Sharon Coleman, Michael C O'Donovan, Paul R Buckland.   

Abstract

The glutathione-S-transferases are a group of enzymes that play a major role in detoxification and defence against toxic, carcinogenic and other compounds. We analysed the proximal promoters of 14 genes encoding glutathione-S-transferase for polymorphism. Ten of the promoters contained sequence variants, nine of which we were able to clone into a reporter gene vector, pGL3. The relative ability of each haplotype to promote transcription of the luciferase gene was tested in each of two human cell lines (HEK293t and TE671) using a cotransfected CMV-SEAP plasmid as a control. Four genes (GSTA1, GSTA2, GSTM4 and GSTT2) showed activity differences greater than 1.5-fold between haplotypes, and a fifth gene (MGST1) showed a 1.4-fold difference. The promoter sequence variants in these genes may therefore play a role in human variation, susceptibility to diseases and the effects of drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128050     DOI: 10.1097/00008571-200401000-00005

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  7 in total

Review 1.  Drug focus: Pharmacogenetic studies related to cyclophosphamide-based therapy.

Authors:  Navin Pinto; Susan M Ludeman; M Eileen Dolan
Journal:  Pharmacogenomics       Date:  2009-12       Impact factor: 2.533

2.  Intervention with cloudy apple juice results in altered biological activities of ileostomy samples collected from individual volunteers.

Authors:  Selvaraju Veeriah; Kamal Kumar Balavenkatraman; Frank- D Böhmer; Kathrin Kahle; Michael Glei; Elke Richling; Wolfgang Scheppach; Beatrice L Pool-Zobel
Journal:  Eur J Nutr       Date:  2008-07-17       Impact factor: 5.614

3.  A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids.

Authors:  Kobra Haghighi; Guoli Chen; Yoji Sato; Guo-Chang Fan; Suiwen He; Fotis Kolokathis; Luke Pater; Ioannis Paraskevaidis; W Keith Jones; Gerald W Dorn; Dimitrios Th Kremastinos; Evangelia G Kranias
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

4.  Quantitative proteomics analysis based on tandem mass tag labeling coupled with labeling coupled with liquid chromatography-tandem mass spectrometry discovers the effect of silibinin on non-alcoholic fatty liver disease in mice.

Authors:  Yichao Wang; Hang Zhao; Liying Yang; He Zhang; Xian Yu; Wenjie Fei; Yunfeng Zhen; Zhe Gao; Shuchun Chen; Luping Ren
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

5.  GSTT2 promoter polymorphisms and colorectal cancer risk.

Authors:  Sang-Geun Jang; Il-Jin Kim; Hio Chung Kang; Hye-Won Park; Sun-A Ahn; Hyun-Ju Yoon; Kun Kim; Hai-Rim Shin; Jin Soo Lee; Jae-Gahb Park
Journal:  BMC Cancer       Date:  2007-01-25       Impact factor: 4.430

6.  Genome-wide discovery of drug-dependent human liver regulatory elements.

Authors:  Robin P Smith; Walter L Eckalbar; Kari M Morrissey; Marcelo R Luizon; Thomas J Hoffmann; Xuefeng Sun; Stacy L Jones; Shelley Force Aldred; Anuradha Ramamoorthy; Zeruesenay Desta; Yunlong Liu; Todd C Skaar; Nathan D Trinklein; Kathleen M Giacomini; Nadav Ahituv
Journal:  PLoS Genet       Date:  2014-10-02       Impact factor: 5.917

7.  Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation.

Authors:  Paula Muñiz; Cristina Andrés-Zayas; Diego Carbonell; María Chicano; Rebeca Bailén; Gillen Oarbeascoa; Julia Suárez-González; Ignacio Gómez Centurión; Nieves Dorado; David Gallardo; Javier Anguita; Mi Kwon; Jose L Díez-Martín; Carolina Martínez-Laperche; Ismael Buño
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.